ĀÜĄņĀŅĀ×

Magdalene Moran, PhD, is a leading scientific researcher in the discovery and early development projects in multiple disease areas. She is a noted expert in the Transient Receptor Potential (TRP) family of ion channels.

Prior to joining Caraway Therapeutics, Dr. Moran was the Senior Vice President of biology at Hydra Biosciences, where she was part of the scientific team for over 15 years. She led discovery and early development projects in pain, pulmonary, CNS, and renal diseases, resulting in six development candidates in six years. In addition, Dr. Moran was the scientific representative for business development activities and coordinated the scientific advisory and medical advisory boards. Before Hydra, Dr. Moran served as a researcher in the laboratory of ion channel expert Dr. David Clapham at Childrenā€™s Hospital in Boston, where she studied the basal transcription machinery and cloned several novel ion channels.

Dr. Moran received her bachelorā€™s degree in biology with a concentration in neuroscience from Williams College and earned her doctorate degree in neurobiology from Harvard University.